Canopy breaks ground on NY hemp industrial park

One of the largest cannabis companies in the world made a significant move into the U.S. hemp industry Monday by breaking ground on a new industrial park for hemp processing in New York. Canadian cannabis pioneer Canopy Growth Corp., based in Smith Falls, Ontario, unveiled plans for its new $150 million Hemp Industrial Park in […]

SOL Global increases ownership stake in HeavenlyRx

Cannabis investment company SOL Global Investments purchased additional common shares to raise its ownership in its CBD-focused wellness subsidiary HeavenlyRx to 44.53%. As part of a larger private offering, the Toronto-based international investment company announced Monday it spent an additional $18.1 million (23.9 million Canadian dollars) on HeavenlyRx. The announcement comes just weeks after Sol […]

Curaleaf scrubs website for medical claims following FDA warning

After federal regulators warned cannabis giant Curaleaf last week against making unsubstantiated medical claims for its CBD products, the company has taken action. The Massachusetts cannabis company removed its blog and deleted social media posts and articles on its website saying its products can be used to treat medical conditions such as cancer, Alzheimer’s disease, chronic […]

Michigan hemp farmers worry privacy law could hurt business

Some in Michigan’s fledgling hemp industry are concerned that a state privacy law preventing agriculture officials from disclosing hemp farmers’ identities and locations could negatively affect their businesses. As a stipulation under the 2018 Farm Bill, applicants who seek to produce and process hemp must give their GPS coordinates. But the Michigan attorney general’s office […]

European Medicines Agency panel OKs GW Pharma’s cannabis drug

GW Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex. The CHMP is responsible for preparing the European Medicines Agency (EMA)’s opinions on questions related to the marketing of human medicines. The CHMP opinion was adopted July 25, and the final decision now rests […]

1 175 176 177 178 179 200
Right Menu Icon